C0003241||antibody
C0444659||merozoite
C0003320||antigens
C0024530||malaria
C0020964||immunity
C0733511||surveillance
C0003241||Antibodies
C0678209||acquired human immunity
C0024535||Plasmodium falciparum (Pf) malaria
C0444659||merozoites
C0005767||blood
C0007590||replication
C0024530||disease
C0444659||Merozoites
C0003320||antigens
C0020962||immune system
C0003241||antibodies
C1314973||responses
C0003320||antigens
C0003241||antibodies
C0003320||antigens
C3714514||infection
C0020964||immunity
C1314973||responses
C0444659||merozoite
C0003320||antigens
C0024530||malaria
C0003241||antibodies
C3714514||infection
C1314973||responses
C3714514||infection
C0003241||antibody
C0003320||antigens
C0003320||antigen
C0024530||malaria
C0003320||Antigen
C1314973||responses
C1314973||response
C0003241||antibodies
C1314973||response
C0003320||antigen
C1314973||responses
C3714514||infection
C1314973||responses
C0086418||human
C0020964||immunity
C0024530||malaria
C0206255||malaria vaccines
C0444659||merozoite
C0003320||antigens
C0003320||antigens
C0024530||malaria
C0733511||surveillance